Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Jian Yang
Pennsylvania State University Univ Park, Department: Biomedical Engineering
Should you be removed from our database? Contact us at [email protected]. Read more below.
Acuitive Technologies
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Some of Dr. Yang’s technologies related to citrate based bone biomaterials have been licensed to Acuitive Technologies, Inc. To that end, Acuitive has asked Dr. Yang to serve as a consultant for the company. He works 125 hours per year, assisting the company in developing its orthopedic technologies. Dr. Yang has indicated that, through this project, he and his research team will be exploring fundamental aspects of citrate mediated bone regeneration to help design better bone biomaterials for orthopedic applications. Technology stemming from this project could potentially be used by the company in the future for orthopedic applications. Given that this particular project could potentially be of interest to Acuitive, our institution determined that a management plan is required.
Citrate Metabonegenic Regulation for the next Generation of Orthopedic Biomaterial Design
Project Narratives The objectives of this project are to elucidate an unexplored metabonegenic regulation of citrate for bone development, and to translate these understandings towards the design of novel biomimetic dynamic citrate- presenting bone biomaterials for orthopedic applications. The novel citrate-presenting biomaterials can address the limitations in the use of the currently available materials including inabilities to mimic the native tissue composition, weak mechanical strength, minimal osteoinductivity, significant inflammatory responses, poor bone integration, and slow bone regeneration.
Filed on May 29, 2018.
Tell us what you know about Jian Yang's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Jian Yang filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Jian Yang | Pennsylvania State University Univ Park | Conflict of Interest | Acuitive Technologies | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.